logo
Elevance Health CEO Boudreaux buys $2.44M of shares

Elevance Health CEO Boudreaux buys $2.44M of shares

Elevance Health (ELV) CEO Gail Boudreaux disclosed the purchase of 8,500 shares at an average price of $286.94 for total value of $2.44M. Boudreaux now owns 151,020 shares of Elevance. Shares of Elevance bounced off their lows but remain down 6% to $283.52 in afternoon trading.
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Ceramic Veneers vs. Porcelain Veneers: Which One Is Better?
Ceramic Veneers vs. Porcelain Veneers: Which One Is Better?

Time Business News

time2 hours ago

  • Time Business News

Ceramic Veneers vs. Porcelain Veneers: Which One Is Better?

When it comes to enhancing your smile, veneers are among the most popular cosmetic dental solutions available. They offer a quick and effective way to correct discolored, chipped, or uneven teeth. But with several materials to choose from, one question comes up often: Ceramic veneers vs. porcelain veneers—which is better? Both options have their strengths and limitations, and the right choice often depends on your personal goals, budget, and dental condition. Let's break it down. Veneers are ultra-thin shells placed over the front surface of teeth to improve their appearance. They are custom-made to match your natural teeth in color, shape, and size. They are commonly used to: Whiten stained teeth Close small gaps Fix chipped or broken teeth Create symmetry Improve overall smile aesthetics Among the many types of materials available, ceramic and porcelain are the most requested for premium aesthetic results. Ceramic veneers refer to restorations made from various types of dental ceramic materials. These include zirconia-based ceramics and lithium disilicate (like IPS They are known for their High strength Durability Natural translucency Biocompatibility Ceramic veneers are often considered a premium option, offering a balance between beauty and toughness. Porcelain is actually a subtype of ceramic, but in dentistry, the term 'porcelain veneers' usually refers to ultra-thin laminates made from feldspathic porcelain—a traditional, hand-layered material known for its outstanding esthetics. Porcelain veneers are ideal for: Patients who want the most natural look Minor cosmetic corrections Light reflection that mimics real enamel They're especially popular among actors, models, and professionals looking for that perfect Hollywood smile. Key Differences Between Ceramic and Porcelain Veneers Reference: Dr. Nico Kamosi (accredited member of IAOMT, SMART certified) – London Specialist Dentists clinic in Knightsbridge, London. Address: Unit A, 4th Floor, 193-195 Brompton Rd, London SW3 1NE If your primary focus is natural beauty and translucency, then porcelain veneers might be the better choice. Their ultra-thin nature and ability to reflect light make them virtually indistinguishable from natural enamel. However, modern ceramic materials have come a long way. High-end ceramics like lithium disilicate offer both strength and good aesthetics, making them ideal for patients who want a balance of both. Ceramic veneers—especially those made from zirconia—are known for their strength and longevity. They are less likely to chip or crack, which makes them better suited for patients who grind their teeth or have bite issues. Porcelain veneers, while strong, can be more prone to chipping under pressure and are generally best for front teeth that experience less bite force. One of the major advantages of porcelain veneers is that they can be applied with minimal tooth reduction. In many cases, the natural tooth structure is barely altered, making the procedure more conservative. Ceramic veneers may require slightly more tooth preparation, depending on the thickness of the material and the desired outcome. Both porcelain and advanced ceramics are biocompatible, meaning they won't irritate the gums or surrounding tissue. However, some patients report better gum response with high-grade ceramic veneers, especially zirconia-based options. Porcelain veneers, particularly those crafted by hand in a dental lab, may take more time to design and fit. Ceramic veneers, especially those made using CAD/CAM technology, can sometimes be fabricated faster—even on the same day in some clinics. Porcelain veneers are typically more affordable than zirconia-based ceramic veneers. However, prices vary depending on: Location Lab expertise Dentist experience Number of teeth being treated Ceramic veneers may come at a higher price but often provide greater durability in the long run. Reference: Dr. Nico Kamosi (accredited member of IAOMT, SMART certified) – London Specialist Dentists clinic in Knightsbridge, London. Address: Unit A, 4th Floor, 193-195 Brompton Rd, London SW3 1NE There is no one-size-fits-all answer. The best veneer for you depends on your specific needs, expectations, and dental condition. Choose porcelain veneers if: You want a highly aesthetic, natural-looking result Your cosmetic concerns are minor You prefer a minimally invasive procedure Choose ceramic veneers if: You prioritize strength and durability You have bite issues or clenching habits You're okay with a slightly thicker restoration Consulting with a skilled cosmetic dentist ensures that you receive the material that best suits your smile goals, facial structure, and lifestyle. TIME BUSINESS NEWS

Wells Fargo Cuts Elevance (ELV) Price Target on Margin Uncertainty
Wells Fargo Cuts Elevance (ELV) Price Target on Margin Uncertainty

Yahoo

time12 hours ago

  • Yahoo

Wells Fargo Cuts Elevance (ELV) Price Target on Margin Uncertainty

Elevance Health, Inc. (NYSE:ELV) ranks among the . Wells Fargo kept its Overweight rating on Elevance Health, Inc. (NYSE:ELV) on July 15, but lowered its price target on the health insurer from $478 to $400. Wells Fargo applied a lower multiple of 10.5x to its 2026 earnings per share projection of $38.05, which is less than the previous multiple of 11.5x. designer491/ Wells Fargo stated that the primary driver of the reduced value multiple was uncertainty regarding margins in the Medicaid, Medicare Advantage (MA), and Health Insurance Exchange (HIX) segments for 2025. The firm also pointed out that there was 'relatively low visibility to improvement in 2026,' especially in the Medicaid and Health Insurance Exchange segments. However, it insisted that Elevance's valuation 'remains compelling once dust settles on estimates.' Elevance Health, Inc. (NYSE:ELV), previously Anthem, Inc., is a leading health-benefits provider in the United States. The company offers medical, pharmaceutical, dental, long-term care, disability, and behavioral health insurance under numerous brands, including Anthem Blue Cross, Blue Shield, Wellpoint, and Carelon. While we acknowledge the potential of ELV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Elevance Health, Inc. (ELV) Downgrades 2025 Earnings Amid Rising Medical Costs
Elevance Health, Inc. (ELV) Downgrades 2025 Earnings Amid Rising Medical Costs

Yahoo

time17 hours ago

  • Yahoo

Elevance Health, Inc. (ELV) Downgrades 2025 Earnings Amid Rising Medical Costs

We recently compiled a list of Elevance Health, Inc. stands third on our list among the most undervalued healthcare stocks. Elevance Health, Inc. (NYSE:ELV) is a major U.S. healthcare company, known for its insurance brands Anthem and WellPoint, and its growing Carelon health services arm. It serves around 45.6 million medical plan members and is recognized for integrating technology and value-based care to improve healthcare delivery. The company is facing increased healthcare utilization and rising medical costs, especially in the ACA and Medicaid segments. This has led to a downgrade in full-year 2025 earnings. A 'market-wide morbidity shift' is evident, with new ACA enrollees using emergency services at nearly double the rate of commercial members, and Medicaid patients showing higher acuity due to redeterminations. Amid these challenges, some investors see Elevance Health, Inc. (NYSE:ELV) as one of the most undervalued stocks in the healthcare sector, given its long-term positioning and strategic adjustments. The company expects a surge in elective procedures by Q4 2025 as members act ahead of expiring tax credits in 2026 that could raise their out-of-pocket costs. To address these pressures, the business is ramping up AI-driven tools for risk detection, care coordination, and operational efficiency. It's also expanding value-based care contracts, particularly in behavioral health and oncology, with over one-third of benefit expenses tied to risk-sharing models. The company is adjusting pricing strategies for ACA plans and advocating for Medicaid access amid potential regulatory changes. A healthcare professional discussing a treatment plan with a patient in an outpatient clinic. Though total membership fell by 212,000 in Q2 due to Medicaid attrition, the Medicare Advantage segment continues to grow. Elevance Health, Inc. (NYSE:ELV) is prioritizing long-term financial stability over aggressive member growth as it navigates rising costs, shifting regulations, and post-pandemic care patterns. While we acknowledge the potential of GOOGL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store